Germany’s IQWiG Pans Pfizer’s Xalkori On Study Results, Side Effects
This article was originally published in The Pink Sheet Daily
Executive Summary
Germany’s IQWiG has shot down Pfizer’s lung cancer treatment, citing questionable study results and no improvement on curbing side effects.